A rare case of retained placenta in a young primigravida with no known risk factors; managed by manual removal of the placenta under general anaesthesia

Authors

  • Ravi Sah Department of Obstetrics and Gynaecology, AIIMS, Rishikesh, Uttarakhand, India
  • Amrita Gaurav Department of Obstetrics and Gynaecology, AIIMS, Rishikesh, Uttarakhand, India
  • Om Kumari Department of Obstetrics and Gynaecology, AIIMS, Rishikesh, Uttarakhand, India
  • Kripa Yadav Department of Obstetrics and Gynaecology, AIIMS, Rishikesh, Uttarakhand, India
  • Nevetha Ravichandran Department of Obstetrics and Gynaecology, AIIMS, Rishikesh, Uttarakhand, India
  • Rajan Kumar Department of Obstetrics and Gynaecology, AIIMS, Rishikesh, Uttarakhand, India
  • Saurabh Kumar Gautam Department of Pathology, AIIMS, Rishikesh, Uttarakhand, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20242101

Keywords:

Retained placenta, Dinoprostone, Manual removal of placenta, Oxytocin

Abstract

A retained placenta is suspected when there is failure of expulsion of the placenta even after 30 minutes of delivery of the fetus. Retained placenta is a common cause of PPH and, hence, a significant cause of maternal mortality and morbidity in developing countries. Thus, early intervention is necessary to prevent this post-delivery of the baby. We present a case of retained placenta in a young primigravida with oligohydramnios with fetal horse horseshoe-shaped kidney and a foetal echogenic bowel loop. Her clinical findings and investigations were not significant at the time of admission. She was induced with dinoprostone gel intra-cervically and delivered via vaginal route. There was failure of expulsion of the placenta even after 30 minutes of delivery of the baby. Inj. syntocin 5 units were given via the umbilical cord. In the event of this failure, the patient was shifted inside the OT, and manual removal of the placenta was done under general anaesthesia f/b evacuation retained bits of placental membranes with ovum forceps under USG guidance. Retained placenta can lead to severe PPH and its consequences in the postpartum period. Thus, it requires timely intervention to prevent PPH and reduce maternal mortality and morbidity. Cases of retained placenta can occur even in the absence of any known identified risk factors and should be managed in a tertiary care centre with OT facilities.

Metrics

Metrics Loading ...

References

Greenbaum S, Wainstock T, Dukler D, Leron E, Erez O. Underlying mechanisms of retained placenta: Evidence from a population-based cohort study. Eur J Obstet Gynecol Reprod Biol. 2017;216:12-7.

Cohen G, Kovo M, Biron-Shental T, Markovitch O, Daykan Y, Schreiber H. Risk factors for retained placenta in a first pregnancy-A clinical trial. Int J Gynaecol Obstet. 2023;163(1):194-201.

Perlman NC, Carusi DA. Retained placenta after vaginal delivery: risk factors and management. Int J Women's Health. 2019:527-34.

Le Gallee M, Lee S, Spence AR, Czuzoj-Shulman N, Klam S, Abenhaim HA. Association Between First-Trimester Bleeding and Retained Placenta Requiring Dilatation and Curettage. J Obstet Gynaecol Can. 2021;43(4):463-8.

Cohen A, Gutman-Ido E, Karavani G, Albeck A, Rosenbloom JI, Shushan A, Chill HH. The association between history of retained placenta and success rate of misoprostol treatment for early pregnancy failure. BMC Womens Health. 2023;23(1):523.

Chongsomchai C, Lumbiganon P, Laopaiboon M. Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. Cochrane Database Syst Rev. 2006;(2):CD004904.

Grillo-Ardila CF, Amaya-Guio J, Ruíz-Parra AI, Amaya-Restrepo JC. Systematic review of prostaglandin analogues for retained placenta. Int J Gynaecol Obstet. 2018;143(1):19-23.

Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A; SCARE Group. The SCARE 2020 Guideline: Updating Consensus Surgical Case Report (SCARE) Guidelines. Int J Surg. 2020;84:226-30.

Weeks AD. The retained placenta. Afr Health Sci. 2001;1(1):36-41.

Kongwattanakul K, Rojanapithayakorn N, Laopaiboon M, Lumbiganon P. Anaesthesia/analgesia for manual removal of retained placenta. Cochrane Database Syst Rev. 2020;6(6):CD013013.

Meyer R, Rottenstreich A, Tsur A, Cahan T, Levin G. Risk factors for third stage placental complications among primigravid women. Placenta. 2020;99:16-20.

Nardin JM, Weeks A, Carroli G. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev. 2011;(5):CD001337.

Grillo‐Ardila CF, Ruiz‐Parra AI, Gaitán HG, Rodriguez‐Malagon N. Prostaglandins for management of retained placenta. Cochr Database of Syst Rev. 2014;5:CD010312.

Maharjan M, Shrestha P, Ghimire S. A rare case of morbidly adherent placenta in a young Primigravida with RH negative pregnancy managed with peripartum subtotal hysterectomy. Int J Surg Case Rep. 2024;114:109121.

AlMousa R, AlMuhaidib HR, Alanezi SM, Al Qahtani N. The rule of ultrasonography in the management of retained placenta. Cureus. 2021;13(1):10.

Vaidya A, Panchbudhe S, Satia M. Conservative management in a case of retained adherent placenta in a primigravida patient. Int J Reproduct Contracept Obstetr Gynecol. 2017;6(7):3188-92.

Downloads

Published

2024-07-29

How to Cite

Sah, R., Gaurav, A., Kumari, O., Yadav, K., Ravichandran, N., Kumar, R., & Gautam, S. K. (2024). A rare case of retained placenta in a young primigravida with no known risk factors; managed by manual removal of the placenta under general anaesthesia. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 13(8), 2199–2202. https://doi.org/10.18203/2320-1770.ijrcog20242101

Issue

Section

Case Reports